Functions and transcriptional regulation of PAH-inducible human UDP- glucuronosyl-transferases

Drug Metabolism Reviews

Volumn 31, Issue 2, 1999, Pages 411-422

  Bock, Karl Walter ^a   Gschaidmeier, Harald ^a   Heel, Horst ^a   Lehmköster, Tobias ^a   Münzel, Peter A ^a   Bock Hennig, Barbara S ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Benzo(a)pyrene metabolism; Human isoforms; Induction by dioxins; UDP glucuronyltransferase

Indexed keywords

BENZO[A]PYRENE; GLUCURONOSYLTRANSFERASE;

ANIMAL TISSUE; CELL SPECIFICITY; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; GENE STRUCTURE; GENETIC POLYMORPHISM; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HUMANS; POLYCYCLIC HYDROCARBONS, AROMATIC; TRANSCRIPTION, GENETIC;

EID: 0032923796     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101927     Document Type: Conference Paper

References (44)

1. A. G. Hildebrandt, Thesis, Medical Faculty, University of Tübingen, 1965.
2. K. W. Bock, W. Fröhling, H. Remmer, and B. Rexer, Biochim. Biophys. Acta, 327, 46 (1973).
3. P. J. Mackenzie, I. S. Owens, B. Burchell, K. W. Bock, A. Bairoch, A. Belanger, S. Fournel-Gigleux, M. Green, D. W. Hum, T. Iyanagi, D. Lancet, P. Louisot, J. Magdalou, J. R. Chowdhury, J. K. Ritter, H. Schachter, T. R. Tephly, K. F. Tipton, and D. W. Nebert, Pharmacogenetics, 7, 255 (1997).
4. G. J. Dutton, Glucuronidation of Drugs and Other Compounds, CRC Press, Boca Raton, FL, 1980, p. 23.
5. D. W. Nebert, Mol. Endocrinol., 5, 1203 (1991).
6. D. W. Nebert, Biochem. Pharmacol., 47, 25 (1994).
7. J. K. Ritter, F. Chen, Y. Y. Sheen, H. M. Tran, S. Kimura, M. T. Yeatman, and I. S. Owens, J. Biol. Chem., 267, 3257 (1992).
8. T. Ebner, R. P. Remmel, and B. Burchell, Mol. Pharmacol., 43, 649 (1993).
9. C. D. King, M. D. Green, G. R. Rios, B. L. Coffman, I. S. Owens, W. P. Bishop, and T. R. Tephly, Arch. Biochem. Biophys., 332, 92 (1996).
10. M. D. Green and T. R. Tephly, Drug Metab. Dispos., 24, 356 (1996).
11. K. W. Bock, A. Forster, H. Gschaidmeier, M. Brück, P. Münzel, W. Schareck, S. Fournel-Gigleux, and B. Burchell, Biochem. Pharmacol., 45, 1809 (1993).
12. T. Ebner and B. Burchell, Drug Metab. Dispos., 21, 50 (1993).
13. C.-J. Jin, J. O. Miners, K. J. Lillywhite, and P. I. Mackenzie, J. Pharm. Exp. Ther., 264, 475 (1993).
14. B. L. Coffman, G. R. Rios, C. D. King, and T. R. Tephly, Drug Metab. Dispos., 25, 1 (1997).
15. M. D. Green, E. M. Oturu, and T. R. Tephly, Drug Metab. Dispos., 22, 799 (1994).
16. C. H. Brierly, S. Bin Senafi, D. Clarke, M.-H. Hsu, E. F. Johnson, and B. Burchell, Adv. Enzyme Regul., 36, 85 (1996).
17. B. Burchell, M. W. H. Coughtrie, and P. L. M. Jansen, Hepatology, 20, 1622 (1994).
18. M. Patel, B. K. Tang, D. M. Grant, and W. Kalow, Pharmacogenetics, 5, 287 (1995).
19. E. Lévesque, M. Beaulieu, M. Green, T. R. Tephly, A. Bélanger, and D. W. Hum, Pharmacogenetics, 7, 317 (1997).
20. J. C. Mucklow, H. S. Fraser, C. J. Bulpitt, C. Kahn, G. Mould, and C. T. Dollery, Br. J. Clin. Pharmacol., 10, 67 (1980).
21. E. J. Pantuck, C. B. Pantuck, K. E. Anderson, L. W. Wattenberg, A. H. Conney, and A. Kappas, Clin. Pharmacol. Ther., 35, 161 (1984).
22. K. W. Bock, J. Wiltfang, R. Blume, D. Ullrich, and J. Bircher, Eur. J. Clin. Pharmacol., 31, 677 (1987).
23. K. W. Bock, D. Schrenk, A. Forster, E.-U. Griese, K. Mörike, D. Brockmeier, and M. Eichelbaum, Pharmacogenetics, 4, 209 (1994).
24. T. Walle, U. K. Walle, T. D. Cowart, E. C. Conradi, and T. E. Gaffney, J. Pharmacol. Exp. Ther., 241, 928 (1987).
25. D. Paul, K. M. Standifer, C. E. Inturrisi, and G. W. Pasternak, J. Pharm. Exp. Ther., 251, 477 (1989).
26. R. Osborne, P. Thompson, S. Joel, D. Trew, N. Patel, and M. Slevin, Br. J. Clin. Pharmacol., 34, 130 (1992).
27. G. C. Rossi, G. P. Brown, L. Leventhal, K. Yang, and G. W. Pasternak, Neurosci. Lett., 216, 1 (1996).
28. P. A. Münzel, G. Bookjans, G. Mehner, T. Lehmköster, and K. W. Bock, Arch. Biochem. Biophys., 335, 205 (1996).
29. D. Ullrich, P. A. Münzel, S. Beck-Gschaidmeier, M. Schröder, and K. W. Bock, Biochem. Pharmacol., 54, 1159 (1997).
30. P. A. Münzel, T. Lehmköster, M. Brück, J. K. Ritter, and K. W. Bock, Arch. Biochem. Biophys., 350, 72 (1998).
31. Y. Emi, S.-I. Ikushiro, and T. Iyanagi, J. Biochem., 117, 392 (1995).
32. P. Talalay, J. W. Fahey, W. D. Holtzclaw, T. Prestera, and Y. Zhang, Toxicol. Lett., 82/83, 173 (1995).
33. J. G. Lamb, P. Straub, and R. H. Tukey, Biochemistry, 39, 10513 (1994).
34. Y. Emi, S.-I. Ikushiro, and T. Iyanagi, J. Biol. Chem., 271, 3952 (1996).
35. E. C. Miller and J. A. Miller, Cancer, 47, 2327 (1981).
36. A. H. Conney, Cancer Res., 42, 4875 (1982).
37. M. Rojas, K. Alexandrov, G. Auburtin, A. Wastiaux-Denamur, L. Mayer, B. Mahieu, P. Sebastien, and H. Bartsch, Carcinogenesis, 16, 1373 (1995).
38. A. D. Grove, F. K. Kessler, R. P. Metz, and J. K. Ritter, J. Biol. Chem., 272, 1621 (1997).
39. D. R. Bevan and V. M. Sadler, Carcinogenesis, 13, 403 (1992).
40. W. Lilienblum, B. S. Bock-Hennig, and K. W. Bock, Mol. Pharmacol., 27, 451 (1985).
41. H. Gschaidmeier, A. Seidel, F. Oesch, B. Burchell, and K. W. Bock, Biochem. Pharmacol., 49, 1601 (1995).
42. C.-J. Jin, J. O. Miners, B. Burchell, and P. I. Mackenzie, Carcinogenesis, 14, 2637 (1993).
43. Z. Hu and P. G. Wells, J. Pharmacol. Exp. Ther., 263, 334 (1992).
44. K. W. Bock, H.-P. Lipp, and B. S. Bock-Hennig, Xenobiotica, 20, 1101 (1990).